Basic Information
| LncRNA/CircRNA Name | CASC11 |
| Synonyms | NA |
| Region | GRCh38_8:127686343-127733967 |
| Ensemble | ENSG00000249375 |
| Refseq | NR_117101 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | HCC tissues,cell lines(SNU-398,SNU-182) |
| Expression Pattern | up-regulated |
| Function Description | we found that CASC11 was up-regulated, while miR-188-5p was down-regulated in tumor tissues of HCC patients. |
| Pubmed ID | 30910841 |
| Year | 2019 |
| Title | LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5p. |
External Links
| Links for CASC11 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |